ID   PPIL2_HUMAN             Reviewed;         520 AA.
AC   Q13356; Q13357; Q8TAH2; Q9BWR8;
DT   10-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   15-MAR-2017, entry version 160.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase-like 2 {ECO:0000305};
DE            Short=PPIase {ECO:0000305};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:11435423};
DE            EC=5.2.1.8 {ECO:0000250|UniProtKB:Q08752, ECO:0000303|PubMed:8660300};
DE   AltName: Full=CYC4 {ECO:0000303|PubMed:11435423};
DE   AltName: Full=Cyclophilin-60 {ECO:0000303|PubMed:8660300};
DE            Short=Cyclophilin-like protein Cyp-60 {ECO:0000303|PubMed:8660300};
DE            Short=Cyp60 {ECO:0000303|PubMed:8660300};
DE            Short=hCyP-60 {ECO:0000303|PubMed:8660300};
DE   AltName: Full=RING-type E3 ubiquitin transferase isomerase-like 2 {ECO:0000305};
DE   AltName: Full=Rotamase PPIL2 {ECO:0000305};
GN   Name=PPIL2 {ECO:0000312|HGNC:HGNC:9261};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Lymphocyte;
RX   PubMed=8660300; DOI=10.1042/bj3140313;
RA   Wang B.B., Hayenga K.J., Payan D.G., Fisher J.M.;
RT   "Identification of a nuclear-specific cyclophilin which interacts with
RT   the proteinase inhibitor eglin c.";
RL   Biochem. J. 314:313-319(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Hippocampus, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11435423; DOI=10.1074/jbc.M102755200;
RA   Hatakeyama S., Yada M., Matsumoto M., Ishida N., Nakayama K.I.;
RT   "U box proteins as a new family of ubiquitin-protein ligases.";
RL   J. Biol. Chem. 276:33111-33120(2001).
RN   [5]
RP   INTERACTION WITH CRNKL1 AND HSP90.
RX   PubMed=15189447; DOI=10.1111/j.1356-9597.2004.00742.x;
RA   Hatakeyama S., Matsumoto M., Yada M., Nakayama K.I.;
RT   "Interaction of U-box-type ubiquitin-protein ligases (E3s) with
RT   molecular chaperones.";
RL   Genes Cells 9:533-548(2004).
RN   [6]
RP   FUNCTION, INTERACTION WITH BSG, AND SUBCELLULAR LOCATION.
RX   PubMed=15946952; DOI=10.1074/jbc.M503770200;
RA   Pushkarsky T., Yurchenko V., Vanpouille C., Brichacek B., Vaisman I.,
RA   Hatakeyama S., Nakayama K.I., Sherry B., Bukrinsky M.I.;
RT   "Cell surface expression of CD147/EMMPRIN is regulated by cyclophilin
RT   60.";
RL   J. Biol. Chem. 280:27866-27871(2005).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-482, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-470, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 280-457.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the human peptidylprolyl isomerase-like 2
RT   isoform B.";
RL   Submitted (JAN-2006) to the PDB data bank.
CC   -!- FUNCTION: May catalyze the cis-trans isomerization of proline
CC       imidic peptide bonds in oligopeptides thereby assisting the
CC       folding of proteins (By similarity). May also function as a
CC       chaperone, playing a role in transport to the cell membrane of BSG
CC       for instance (PubMed:15946952). May also have a protein ubiquitin
CC       ligase activity acting as an E3 ubiquitin protein ligase or as an
CC       ubiquitin-ubiquitin ligase promoting elongation of ubiquitin
CC       chains on substrates. By mediating 'Lys-48'-linked
CC       polyubiquitination of proteins could target them for proteasomal
CC       degradation (PubMed:11435423). {ECO:0000250|UniProtKB:Q08752,
CC       ECO:0000269|PubMed:11435423, ECO:0000269|PubMed:15946952,
CC       ECO:0000303|PubMed:8660300}.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0). {ECO:0000250|UniProtKB:Q08752,
CC       ECO:0000303|PubMed:8660300}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:11435423}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:11435423}.
CC   -!- SUBUNIT: Interacts with BSG. Interacts (via the PPIase
CC       cyclophilin-type domain) with CRNKL1; they may form a trimeric
CC       complex with HSP90. {ECO:0000269|PubMed:15189447,
CC       ECO:0000269|PubMed:15946952}.
CC   -!- INTERACTION:
CC       P36406:TRIM23; NbExp=3; IntAct=EBI-7705988, EBI-740098;
CC       Q96NB3:ZNF830; NbExp=2; IntAct=EBI-7705988, EBI-3920997;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11435423,
CC       ECO:0000269|PubMed:8660300}. Note=May also localize to the
CC       cytoplasm and the cell membrane. {ECO:0000269|PubMed:15946952}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13356-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13356-2; Sequence=VSP_005182;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highest expression in thymus, pancreas and
CC       testis. Also detected in heart, placenta, lung, liver, skeletal
CC       muscle, kidney, spleen, prostate, ovary, small intestine and
CC       colon. Poorly detected in brain and leukocytes. Strong protein
CC       expression in lymph node (cortical, paracortical and medullar
CC       regions), thyroid (follicular epithelial cells), testis
CC       (developing spermatozoa), stomach (cells lining the gastric pit),
CC       pancreas, kidney (proximal and distal-tubule cells and collecting
CC       duct cells but not in glomeruli), endometrium and colon (goblet
CC       cells). Moderate protein expression in spleen, prostate
CC       (epithelium and squamous cell carcinomas), placenta and adrenal
CC       gland. Weak protein expression in liver, heart, breast, ovary, and
CC       lung. No protein expression in brain and bladder. High protein
CC       expression in most lymphomas and melanomas.
CC       {ECO:0000269|PubMed:11435423, ECO:0000269|PubMed:8660300}.
CC   -!- SIMILARITY: Belongs to the cyclophilin-type PPIase family. PPIL2
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U37219; AAC50376.1; -; mRNA.
DR   EMBL; U37220; AAC50377.1; -; mRNA.
DR   EMBL; U37221; AAC50378.1; -; mRNA.
DR   EMBL; CR456548; CAG30434.1; -; mRNA.
DR   EMBL; BC028385; AAH28385.1; -; mRNA.
DR   EMBL; BC000022; AAH00022.1; -; mRNA.
DR   CCDS; CCDS13793.1; -. [Q13356-1]
DR   CCDS; CCDS46670.1; -. [Q13356-2]
DR   PIR; S64705; S64705.
DR   RefSeq; NP_001304925.1; NM_001317996.1. [Q13356-1]
DR   RefSeq; NP_055152.1; NM_014337.3. [Q13356-1]
DR   RefSeq; NP_680480.1; NM_148175.2. [Q13356-1]
DR   RefSeq; NP_680481.1; NM_148176.2. [Q13356-2]
DR   RefSeq; XP_005261505.1; XM_005261448.3. [Q13356-1]
DR   RefSeq; XP_011528348.1; XM_011530046.2. [Q13356-1]
DR   RefSeq; XP_011528349.1; XM_011530047.2. [Q13356-1]
DR   UniGene; Hs.438587; -.
DR   PDB; 1ZKC; X-ray; 1.65 A; A/B=280-457.
DR   PDBsum; 1ZKC; -.
DR   ProteinModelPortal; Q13356; -.
DR   SMR; Q13356; -.
DR   BioGrid; 117260; 27.
DR   IntAct; Q13356; 15.
DR   MINT; MINT-4654541; -.
DR   STRING; 9606.ENSP00000390427; -.
DR   iPTMnet; Q13356; -.
DR   PhosphoSitePlus; Q13356; -.
DR   BioMuta; PPIL2; -.
DR   DMDM; 23813917; -.
DR   EPD; Q13356; -.
DR   MaxQB; Q13356; -.
DR   PaxDb; Q13356; -.
DR   PeptideAtlas; Q13356; -.
DR   PRIDE; Q13356; -.
DR   DNASU; 23759; -.
DR   Ensembl; ENST00000335025; ENSP00000334553; ENSG00000100023. [Q13356-1]
DR   Ensembl; ENST00000398831; ENSP00000381812; ENSG00000100023. [Q13356-1]
DR   Ensembl; ENST00000406385; ENSP00000384299; ENSG00000100023. [Q13356-1]
DR   Ensembl; ENST00000626352; ENSP00000486725; ENSG00000100023. [Q13356-2]
DR   GeneID; 23759; -.
DR   KEGG; hsa:23759; -.
DR   UCSC; uc002zvg.5; human. [Q13356-1]
DR   CTD; 23759; -.
DR   DisGeNET; 23759; -.
DR   GeneCards; PPIL2; -.
DR   HGNC; HGNC:9261; PPIL2.
DR   HPA; HPA035344; -.
DR   HPA; HPA055637; -.
DR   MIM; 607588; gene.
DR   neXtProt; NX_Q13356; -.
DR   OpenTargets; ENSG00000100023; -.
DR   PharmGKB; PA33588; -.
DR   eggNOG; KOG0883; Eukaryota.
DR   eggNOG; COG0652; LUCA.
DR   GeneTree; ENSGT00760000119072; -.
DR   HOGENOM; HOG000177172; -.
DR   HOVERGEN; HBG053655; -.
DR   InParanoid; Q13356; -.
DR   KO; K10598; -.
DR   OMA; FEYPVCT; -.
DR   OrthoDB; EOG091G05AW; -.
DR   PhylomeDB; Q13356; -.
DR   TreeFam; TF300854; -.
DR   Reactome; R-HSA-210991; Basigin interactions.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; PPIL2; human.
DR   EvolutionaryTrace; Q13356; -.
DR   GeneWiki; PPIL2; -.
DR   GenomeRNAi; 23759; -.
DR   PRO; PR:Q13356; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100023; -.
DR   CleanEx; HS_PPIL2; -.
DR   ExpressionAtlas; Q13356; baseline and differential.
DR   Genevisible; Q13356; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:MGI.
DR   GO; GO:0034450; F:ubiquitin-ubiquitin ligase activity; IDA:MGI.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IMP:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; IDA:MGI.
DR   Gene3D; 2.40.100.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom.
DR   InterPro; IPR024936; Cyclophilin-type_PPIase.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   InterPro; IPR003613; Ubox_domain.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR11071; PTHR11071; 1.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SMART; SM00504; Ubox; 1.
DR   SUPFAM; SSF50891; SSF50891; 1.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
DR   PROSITE; PS51698; U_BOX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Coiled coil;
KW   Complete proteome; Isomerase; Nucleus; Phosphoprotein;
KW   Reference proteome; Rotamase; Transferase; Ubl conjugation pathway.
FT   CHAIN         1    520       Peptidyl-prolyl cis-trans isomerase-like
FT                                2.
FT                                /FTId=PRO_0000064171.
FT   DOMAIN       35    108       U-box.
FT   DOMAIN      278    433       PPIase cyclophilin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00156}.
FT   COILED      197    217       {ECO:0000255}.
FT   MOD_RES     470    470       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     482    482       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ     490    520       KRAAEEEPSTSATVPMSKKKPSRGFGDFSSW -> EQQRKS
FT                                PQPVPLSPCPRRSPVGVLGTSAPGSSRLPDDH (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_005182.
FT   CONFLICT    455    455       V -> I (in Ref. 3; AAH28385).
FT                                {ECO:0000305}.
FT   STRAND      280    286       {ECO:0000244|PDB:1ZKC}.
FT   STRAND      289    295       {ECO:0000244|PDB:1ZKC}.
FT   TURN        297    299       {ECO:0000244|PDB:1ZKC}.
FT   HELIX       301    312       {ECO:0000244|PDB:1ZKC}.
FT   TURN        313    318       {ECO:0000244|PDB:1ZKC}.
FT   STRAND      323    325       {ECO:0000244|PDB:1ZKC}.
FT   TURN        326    328       {ECO:0000244|PDB:1ZKC}.
FT   STRAND      329    332       {ECO:0000244|PDB:1ZKC}.
FT   STRAND      337    340       {ECO:0000244|PDB:1ZKC}.
FT   STRAND      365    368       {ECO:0000244|PDB:1ZKC}.
FT   STRAND      380    385       {ECO:0000244|PDB:1ZKC}.
FT   HELIX       388    390       {ECO:0000244|PDB:1ZKC}.
FT   TURN        391    393       {ECO:0000244|PDB:1ZKC}.
FT   STRAND      396    402       {ECO:0000244|PDB:1ZKC}.
FT   HELIX       404    412       {ECO:0000244|PDB:1ZKC}.
FT   TURN        417    419       {ECO:0000244|PDB:1ZKC}.
FT   STRAND      422    424       {ECO:0000244|PDB:1ZKC}.
FT   STRAND      427    435       {ECO:0000244|PDB:1ZKC}.
FT   HELIX       439    455       {ECO:0000244|PDB:1ZKC}.
SQ   SEQUENCE   520 AA;  58823 MW;  3FFA51C3D82F0957 CRC64;
     MGKRQHQKDK MYITCAEYTH FYGGKKPDLP QTNFRRLPFD HCSLSLQPFV YPVCTPDGIV
     FDLLNIVPWL KKYGTNPSNG EKLDGRSLIK LNFSKNSEGK YHCPVLFTVF TNNTHIVAVR
     TTGNVYAYEA VEQLNIKAKN FRDLLTDEPF SRQDIITLQD PTNLDKFNVS NFYHVKNNMK
     IIDPDEEKAK QDPSYYLKNT NAETRETLQE LYKEFKGDEI LAATMKAPEK KKVDKLNAAH
     YSTGKVSASF TSTAMVPETT HEAAAIDEDV LRYQFVKKKG YVRLHTNKGD LNLELHCDLT
     PKTCENFIRL CKKHYYDGTI FHRSIRNFVI QGGDPTGTGT GGESYWGKPF KDEFRPNLSH
     TGRGILSMAN SGPNSNRSQF FITFRSCAYL DKKHTIFGRV VGGFDVLTAM ENVESDPKTD
     RPKEEIRIDA TTVFVDPYEE ADAQIAQERK TQLKVAPETK VKSSQPQAGS QGPQTFRQGV
     GKYINPAATK RAAEEEPSTS ATVPMSKKKP SRGFGDFSSW
//
